Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Primer on Pacira Pharma
Seeking Alpha
Wednesday, April 27, 2011 - 11:15am
tags:
Pacira, EXPAREL
Earnings Preview: Bristol-Myers reports 1Q results
Yahoo/AP
Wednesday, April 27, 2011 - 11:14am
tags:
earnings, Bristol-Myers Squibb
Merck: FDA Hep C Panel Live Blog
TheStreet.com
Wednesday, April 27, 2011 - 11:11am
tags:
Merck, advisory panels, FDA, hepatitis C, Vertex Pharmaceuticals, Boceprevir
J&J to Buy Synthes for $21.3 Billion
New York Times
Wednesday, April 27, 2011 - 8:57am
tags:
JNJ, Synthes, M&A
FDA approves GlaxoSmithKline drug Lamictal for seizures
Bizjournals.com
Tuesday, April 26, 2011 - 3:02pm
tags:
Lamictal, FDA, GSK, partial seizures
Genzyme files two new Synvisc lawsuits
Bizjournals.com
Tuesday, April 26, 2011 - 3:01pm
tags:
Genzyme, Synvisc, Sanofi, osteoarthritis
Earnings Preview: Watson Pharma
Yahoo/Zacks.com
Tuesday, April 26, 2011 - 3:00pm
tags:
Watson Pharmaceuticals, earnings, Pfizer, JNJ
Painkillers make antidepressants less effective, study shows
Globe and Mail, Canada
Tuesday, April 26, 2011 - 8:55am
tags:
painkillers, antidepressants
Abbott drug, statin combo can cause heart problems: FDA
Chicago Business, IL
Tuesday, April 26, 2011 - 8:53am
tags:
FDA, statins, Abbott Laboratories, TriLipix
Keryx Biopharmaceuticals: A Bullish Biopharma Play With Protection
Seeking Alpha
Tuesday, April 26, 2011 - 8:49am
tags:
Keryx, cancer, kidney failure
Lupin Signs License Agreement With Abbott for Antara Patents
Bloomberg
Tuesday, April 26, 2011 - 8:48am
tags:
Antara, Abbott Laboratories, Lupin, India
FDA: Tysabri risks greatest during year 3
Fierce Pharma
Tuesday, April 26, 2011 - 6:21am
tags:
FDA, Biogen Idec, Tysabri, MS, multiple sclerosis
Pain Therapeutics says study indicates Remoxy may be less of a target for abuse than OxyContin
Yahoo/AP
Tuesday, April 26, 2011 - 6:19am
tags:
Pain Therapeutics, Remoxy, oxycontin
Savient Pharma: Cheap Biotech Without FDA Approval Risk
Seeking Alpha
Tuesday, April 26, 2011 - 6:18am
tags:
Savient, gout, Krystexxa
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
Bloomberg
Tuesday, April 26, 2011 - 6:17am
tags:
Merck, cervical cancer, Qiagen, Rwanda, HPV, Gardasil, vaccines
IntelliPharmaCeutics: CEO Speaks of Multiple Deals, FDA Catalysts in the Works
Seeking Alpha
Tuesday, April 26, 2011 - 6:16am
tags:
Intellipharmaceutics, FDA
Push to spur more drugs for deadly rare diseases
Yahoo/AP
Tuesday, April 26, 2011 - 6:15am
tags:
orphan drugs
Celgene Poised to Bounce Back After Revlimid Safety Blues
Seeking Alpha
Monday, April 25, 2011 - 10:25pm
tags:
Celgene, Revlimid, drug safety, Multiple Myeloma
Pfizer Scrambles to Reassure Investors on RA Drug Deaths
Motley Fool
Monday, April 25, 2011 - 10:24pm
tags:
Pfizer, investors, rheumatoid arthritis, tofacitinib
Dendreon: Q1 Earnings Preview
Seeking Alpha
Monday, April 25, 2011 - 5:35pm
tags:
earnings, Dendreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.